focus -WSS

focus

author：entertainment 2025-09-30 21:07:33 - browse：612

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter:

The Food and Drug Administration’s decision in June to grant conditional approval to a gene therapy for Duchenne muscular dystrophy was a watershed moment for the treatment of the neuromuscular disease, and a big win for its maker, Sarepta Therapeutics. Confirming the gene therapy’s benefit — and potentially broadening its use to include older boys — will be determined by a Phase 3 clinical trial that will read out later this quarter.

Pfizeris developing its own gene therapy for Duchenne in a fully enrolled Phase 3 study with final results expected in 2024. But before the verdict is revealed, Pfizer intends to conduct an interim analysis later this quarter. The most likely outcome of this early look will be a determination to continue the study to its completion. But surprises — including an early stop for overwhelming efficacy — can’t be ruled out.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Indictment alleges Trump's ex

hotspot

WSS

Megan Rapinoe shares emotional post following US Women's World Cup exit

Maui wildfire now ranks as the fifth

Doulas covered by Medicaid under New York's new plan

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Three issues to watch in global health in 2024

Bird flu researchers hone in on Finland’s mink farms

focus

focus

Wikipedia

At least 13 dead in Texas as scorching temps continue

YouTube cracks down on misinformation on cancer treatment

Duchenne breakthrough therapy leaves behind pioneering families

Designating disabled people as health disparity population is crucial

Guidelines to prevent youth baseball injuries need more muscle

Caregivers of transplant patients call for more support, training

As demand for Covid shots wanes, Moderna seeks its next success

Be careful with at

Continuity nursing helped my family in our darkest PICU moments

HHS names first

focus

Designating disabled people as health disparity population is crucial

Biden administration begins canceling student loan debt for 804,000 borrowers

Biden administration begins canceling student loan debt for 804,000 borrowers

Indictment alleges Trump's ex

Megan Rapinoe shares emotional post following US Women's World Cup exit

BMS, looking to build heart drug business, turns to AI for diagnosis

hotspot

hotspot

hotspot

focus